A detailed history of Consilio Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Consilio Wealth Advisors, LLC holds 2,207 shares of ABBV stock, worth $387,063. This represents 0.18% of its overall portfolio holdings.

Number of Shares
2,207
Previous 1,813 21.73%
Holding current value
$387,063
Previous $310,000 40.32%
% of portfolio
0.18%
Previous 0.14%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$163.84 - $199.33 $64,552 - $78,536
394 Added 21.73%
2,207 $435,000
Q2 2024

Jul 12, 2024

SELL
$154.79 - $180.76 $14,085 - $16,449
-91 Reduced 4.78%
1,813 $310,000
Q1 2024

Apr 18, 2024

BUY
$159.82 - $182.1 $31,164 - $35,509
195 Added 11.41%
1,904 $346,000
Q4 2023

Jan 11, 2024

BUY
$137.6 - $154.97 $235,158 - $264,843
1,709 New
1,709 $264,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Consilio Wealth Advisors, LLC Portfolio

Follow Consilio Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consilio Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Consilio Wealth Advisors, LLC with notifications on news.